These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9137471)

  • 1. Genistein inhibits proliferation and in vitro invasive potential of human prostatic cancer cell lines.
    Santibáñez JF; Navarro A; Martínez J
    Anticancer Res; 1997; 17(2A):1199-204. PubMed ID: 9137471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer.
    Naik HR; Lehr JE; Pienta KJ
    Anticancer Res; 1994; 14(6B):2617-9. PubMed ID: 7872690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferation effect and mechanism of prostate cancer cell lines as affected by isoflavones from soybean cake.
    Wang BF; Wang JS; Lu JF; Kao TH; Chen BH
    J Agric Food Chem; 2009 Mar; 57(6):2221-32. PubMed ID: 19292464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of growth-inhibitory effects of isoflavones and their metabolites on human breast and prostate cancer cell lines.
    Xiang H; Schevzov G; Gunning P; Williams HM; Silink M
    Nutr Cancer; 2002; 42(2):224-32. PubMed ID: 12416264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro.
    Hedlund TE; Johannes WU; Miller GJ
    Prostate; 2003 Jan; 54(1):68-78. PubMed ID: 12481257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced isoflavone metabolites formed by the human gut microflora suppress growth but do not affect DNA integrity of human prostate cancer cells.
    Raschke M; Wähälä K; Pool-Zobel BL
    Br J Nutr; 2006 Sep; 96(3):426-34. PubMed ID: 16925846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells.
    Katdare M; Osborne M; Telang NT
    Int J Oncol; 2002 Oct; 21(4):809-15. PubMed ID: 12239620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
    Guo Y; Wang S; Hoot DR; Clinton SK
    J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of mammalian lignans on the growth of prostate cancer cell lines.
    Lin X; Switzer BR; Demark-Wahnefried W
    Anticancer Res; 2001; 21(6A):3995-9. PubMed ID: 11911282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity.
    Ouchi H; Ishiguro H; Ikeda N; Hori M; Kubota Y; Uemura H
    Int J Urol; 2005 Jan; 12(1):73-80. PubMed ID: 15661057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145.
    Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():251-64. PubMed ID: 17564322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract.
    Yanagihara K; Ito A; Toge T; Numoto M
    Cancer Res; 1993 Dec; 53(23):5815-21. PubMed ID: 8242641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined effects of terazosin and genistein on a metastatic, hormone-independent human prostate cancer cell line.
    Chang KL; Cheng HL; Huang LW; Hsieh BS; Hu YC; Chih TT; Shyu HW; Su SJ
    Cancer Lett; 2009 Apr; 276(1):14-20. PubMed ID: 19091461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bicalutamide dose-dependently inhibits proliferation in human prostatic carcinoma cell lines and primary cultures.
    Vicentini C; Festuccia C; Angelucci A; Gravina GL; Muzi P; Eleuterio E; Miano R; Marronaro A; Tubaro A; Bologna M
    Anticancer Res; 2002; 22(5):2917-22. PubMed ID: 12530018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo.
    Dorai T; Cao YC; Dorai B; Buttyan R; Katz AE
    Prostate; 2001 Jun; 47(4):293-303. PubMed ID: 11398177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
    Siu SW; Lau KW; Tam PC; Shiu SY
    Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
    Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells.
    Waghray A; Webber MM
    Clin Cancer Res; 1995 Jul; 1(7):747-53. PubMed ID: 9816041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway.
    Xu L; Bergan RC
    Mol Pharmacol; 2006 Sep; 70(3):869-77. PubMed ID: 16772519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.